Literature DB >> 25427547

Exploring the social meaning of curing HIV: a qualitative study of people who inject drugs in Guangzhou, China.

Carissa E Chu1, Feng Wu, Xi He, Qingyan Ma, Yu Cheng, Weiping Cai, Paul Volberding, Joseph D Tucker.   

Abstract

Our objective was to explore the social meaning of HIV and perceptions of an HIV cure among people who inject drugs (PWID) in Guangzhou, China, which speaks to ethical and resource challenges to development in this field. We conducted a qualitative research study using in-depth interviews. We analyzed interview transcripts from 29 PWID, eight physicians, and three social workers from an outpatient HIV clinic and two methadone maintenance treatment centers. The social meaning of HIV infection and perceptions of an HIV cure reflected patients' relationships with society, health systems, and physicians. First, HIV infection decreased perceived social worth and disrupted peer relationships. The possibility of being cured renewed patient hope for regaining physical well-being and achieving social mobility. However, the existence of a cure may not alter the HIV-related stigma due to its association with stigmatized behaviors and marginalized groups. Second, although stigma was a significant barrier to engagement in health care, hope for a cure may outweigh fears of stigma and enhance linkage to HIV testing and treatment as well as methadone services. A cure may exacerbate perceived health disparities if inaccessible to key affected populations such as PWID. The social implications of an HIV cure among this key affected population may inform the design and implementation of cure clinical trials. Careful management of patient expectations, focusing research on key affected populations, expanding HIV testing and treatment systems, improving access to harm reduction programs, and ensuring post-trial access are important considerations for HIV cure research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25427547      PMCID: PMC4287130          DOI: 10.1089/AID.2014.0200

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  28 in total

1.  Illness narratives: time, hope and HIV.

Authors:  D Ezzy
Journal:  Soc Sci Med       Date:  2000-03       Impact factor: 4.634

2.  Trial of antiretroviral for HIV prevention on hold.

Authors:  Khabir Ahmad
Journal:  Lancet Infect Dis       Date:  2004-10       Impact factor: 25.071

3.  The social structural production of HIV risk among injecting drug users.

Authors:  Tim Rhodes; Merrill Singer; Philippe Bourgois; Samuel R Friedman; Steffanie A Strathdee
Journal:  Soc Sci Med       Date:  2005-03-19       Impact factor: 4.634

4.  HIV testing and disclosure: a qualitative analysis of TB patients in South Africa.

Authors:  A Daftary; N Padayatchi; M Padilla
Journal:  AIDS Care       Date:  2007-04

Review 5.  The role of qualitative research in HIV/AIDS.

Authors:  R Power
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

6.  The heroin copping area. A location for epidemiological study and intervention activity.

Authors:  P H Hughes; J H Jaffe
Journal:  Arch Gen Psychiatry       Date:  1971-05

7.  Self-reported antiretroviral therapy in injection drug users.

Authors:  D D Celentano; D Vlahov; S Cohn; V M Shadle; O Obasanjo; R D Moore
Journal:  JAMA       Date:  1998-08-12       Impact factor: 56.272

8.  Social support, medication compliance and HIV/AIDS.

Authors:  Lisa E Cox
Journal:  Soc Work Health Care       Date:  2002

Review 9.  Evolution of China's response to HIV/AIDS.

Authors:  Zunyou Wu; Sheena G Sullivan; Yu Wang; Mary Jane Rotheram-Borus; Roger Detels
Journal:  Lancet       Date:  2007-02-24       Impact factor: 202.731

10.  Clinical trials and medical care: defining the therapeutic misconception.

Authors:  Gail E Henderson; Larry R Churchill; Arlene M Davis; Michele M Easter; Christine Grady; Steven Joffe; Nancy Kass; Nancy M P King; Charles W Lidz; Franklin G Miller; Daniel K Nelson; Jeffrey Peppercorn; Barbra Bluestone Rothschild; Pamela Sankar; Benjamin S Wilfond; Catherine R Zimmer
Journal:  PLoS Med       Date:  2007-11-27       Impact factor: 11.069

View more
  24 in total

1.  International AIDS Society global scientific strategy: towards an HIV cure 2016.

Authors:  Steven G Deeks; Sharon R Lewin; Anna Laura Ross; Jintanat Ananworanich; Monsef Benkirane; Paula Cannon; Nicolas Chomont; Daniel Douek; Jeffrey D Lifson; Ying-Ru Lo; Daniel Kuritzkes; David Margolis; John Mellors; Deborah Persaud; Joseph D Tucker; Françoise Barre-Sinoussi; Galit Alter; Judith Auerbach; Brigitte Autran; Dan H Barouch; Georg Behrens; Marina Cavazzana; Zhiwei Chen; Éric A Cohen; Giulio Maria Corbelli; Serge Eholié; Nir Eyal; Sarah Fidler; Laurindo Garcia; Cynthia Grossman; Gail Henderson; Timothy J Henrich; Richard Jefferys; Hans-Peter Kiem; Joseph McCune; Keymanthri Moodley; Peter A Newman; Monique Nijhuis; Moses Supercharger Nsubuga; Melanie Ott; Sarah Palmer; Douglas Richman; Asier Saez-Cirion; Matthew Sharp; Janet Siliciano; Guido Silvestri; Jerome Singh; Bruno Spire; Jeffrey Taylor; Martin Tolstrup; Susana Valente; Jan van Lunzen; Rochelle Walensky; Ira Wilson; Jerome Zack
Journal:  Nat Med       Date:  2016-07-11       Impact factor: 53.440

2.  Overcoming HIV Stigma? A Qualitative Analysis of HIV Cure Research and Stigma Among Men Who Have Sex with Men Living with HIV.

Authors:  Feng Wu; Alice Zhang; Andrew Babbitt; Qingyan Ma; Nir Eyal; Xin Pan; Weiping Cai; Fengyu Hu; Yu Cheng; Joseph D Tucker
Journal:  Arch Sex Behav       Date:  2017-11-17

Review 3.  Why and where an HIV cure is needed and how it might be achieved.

Authors:  Thumbi Ndung'u; Joseph M McCune; Steven G Deeks
Journal:  Nature       Date:  2019-12-18       Impact factor: 49.962

4.  Physician perceptions of HIV cure in China: A mixed methods review and implications for HIV cure research.

Authors:  Zachary Clarke Rich; Chuncheng Liu; Qingyan Ma; Fengyu Hu; Weiping Cai; Xiaoping Tang; Joseph David Tucker
Journal:  Asian Pac J Trop Dis       Date:  2015-08-14

5.  Acceptability of Cell and Gene Therapy for Curing HIV Infection Among People Living with HIV in the Northwestern United States: A Qualitative Study.

Authors:  Karine Dubé; Jane Simoni; Michael Louella; Laurie Sylla; Zahra H Mohamed; Hursch Patel; Stuart Luter; Ann C Collier
Journal:  AIDS Res Hum Retroviruses       Date:  2019-05-21       Impact factor: 2.205

6.  Designing an Individually Tailored Multilevel Intervention to Increase Engagement in HIV and Substance Use Treatment Among People Who Inject Drugs With HIV: HPTN 074.

Authors:  Kathryn E Lancaster; William C Miller; Tetiana Kiriazova; Riza Sarasvita; Quynh Bui; Tran Viet Ha; Kostyantyn Dumchev; Hepa Susami; Erica L Hamilton; Scott Rose; Rebecca B Hershow; Vivian F Go; David Metzger; Irving F Hoffman; Carl A Latkin
Journal:  AIDS Educ Prev       Date:  2019-04

7.  What Would an HIV Cure Mean to You? Qualitative Analysis from a Crowdsourcing Contest in Guangzhou, China.

Authors:  Alice Zhang; Xin Pan; Feng Wu; Yang Zhao; Fengyu Hu; Linghua Li; Weiping Cai; Joseph D Tucker
Journal:  AIDS Res Hum Retroviruses       Date:  2017-10-12       Impact factor: 2.205

8.  Towards Multidisciplinary HIV-Cure Research: Integrating Social Science with Biomedical Research.

Authors:  Cynthia I Grossman; Anna Laura Ross; Judith D Auerbach; Jintanat Ananworanich; Karine Dubé; Joseph D Tucker; Veronica Noseda; Cristina Possas; Dianne M Rausch
Journal:  Trends Microbiol       Date:  2015-11-28       Impact factor: 17.079

9.  Indirect Benefits in HIV Cure Clinical Research: A Qualitative Analysis.

Authors:  Adam Gilbertson; Elizabeth Poole Kelly; Stuart Rennie; Gail Henderson; JoAnn Kuruc; Joseph D Tucker
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-22       Impact factor: 2.205

10.  If We Build It, Will They Come? Perceptions of HIV Cure-Related Research by People Living with HIV in Four U.S. Cities: A Qualitative Focus Group Study.

Authors:  Laurie Sylla; David Evans; Jeff Taylor; Adam Gilbertson; David Palm; Judith D Auerbach; Karine Dubé
Journal:  AIDS Res Hum Retroviruses       Date:  2018-01       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.